Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles
- PMID: 35680110
- PMCID: PMC9169426
- DOI: 10.1016/j.ijpharm.2022.121893
Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles
Keywords: Alveolar macrophages; Autophagy induction; Host-directed therapy; Innate immunity; Mycobacterium tuberculosis; Nanoparticles.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
The Macrophage Response to Mycobacterium tuberculosis and Opportunities for Autophagy Inducing Nanomedicines for Tuberculosis Therapy.Front Cell Infect Microbiol. 2021 Feb 8;10:618414. doi: 10.3389/fcimb.2020.618414. eCollection 2020. Front Cell Infect Microbiol. 2021. PMID: 33628745 Free PMC article. Review.
-
Autophagy: A new strategy for host-directed therapy of tuberculosis.Virulence. 2019 Dec;10(1):448-459. doi: 10.1080/21505594.2018.1536598. Epub 2018 Nov 2. Virulence. 2019. PMID: 30322337 Free PMC article. Review.
-
Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of Mycobacterium tuberculosis.Autophagy. 2020 Jun;16(6):1021-1043. doi: 10.1080/15548627.2019.1658436. Epub 2019 Sep 8. Autophagy. 2020. PMID: 31462144 Free PMC article.
-
Mycobacterium tuberculosis PPE51 Inhibits Autophagy by Suppressing Toll-Like Receptor 2-Dependent Signaling.mBio. 2022 Jun 28;13(3):e0297421. doi: 10.1128/mbio.02974-21. Epub 2022 Apr 25. mBio. 2022. PMID: 35467412 Free PMC article.
-
Mycobacterium tuberculosis Infection and Innate Responses in a New Model of Lung Alveolar Macrophages.Front Immunol. 2018 Mar 12;9:438. doi: 10.3389/fimmu.2018.00438. eCollection 2018. Front Immunol. 2018. PMID: 29593716 Free PMC article.
Cited by
-
Nanosized Drug Delivery Systems to Fight Tuberculosis.Pharmaceutics. 2023 Jan 24;15(2):393. doi: 10.3390/pharmaceutics15020393. Pharmaceutics. 2023. PMID: 36839715 Free PMC article. Review.
References
-
- Abed N., Couvreur P. Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections. Int. J. Antimicrob. Agents. 2014;43:485–496. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical